8-K/A

CURRENT REPORT AMENDMENT

Company: TENAX THERAPEUTICS, INC.
Filed: December 20, 2013
Period of Report: December 4, 2013
Accession Number: 0001354488-13-006974

View Document ↗ View on SEC.gov ↗